List of Excipients in API RISEDRONATE SODIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing RISEDRONATE SODIUM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Allergan Inc | ACTONEL | risedronate sodium | 0430-0471 | CELLULOSE, MICROCRYSTALLINE | |
| Allergan Inc | ACTONEL | risedronate sodium | 0430-0471 | CROSPOVIDONE | |
| Allergan Inc | ACTONEL | risedronate sodium | 0430-0471 | FERRIC OXIDE YELLOW | |
| Allergan Inc | ACTONEL | risedronate sodium | 0430-0471 | HYDROXYPROPYL CELLULOSE | |
| Allergan Inc | ACTONEL | risedronate sodium | 0430-0471 | HYPROMELLOSES | |
| Allergan Inc | ACTONEL | risedronate sodium | 0430-0471 | LACTOSE MONOHYDRATE | |
| Allergan Inc | ACTONEL | risedronate sodium | 0430-0471 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing RISEDRONATE SODIUM
Detailed excipient profiles for RISEDRONATE SODIUM
Excipient focus: ANHYDROUS LACTOSE
RISEDRONATE SODIUM drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | risedronate sodium | 33342-107 |
| Apotex Corp | risedronate sodium | 60505-3165 |
| Proficient Rx LP | risedronate sodium | 71205-714 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
RISEDRONATE SODIUM drug variants containing CELLULOSE, MICROCRYSTALLINE
RISEDRONATE SODIUM drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-3099 |
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-7771 |
| Apotex Corp | risedronate sodium | 60505-3165 |
| Proficient Rx LP | risedronate sodium | 71205-714 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE
RISEDRONATE SODIUM drug variants containing CROSCARMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | risedronate sodium | 47335-666 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing CROSCARMELLOSE
Excipient focus: CROSCARMELLOSE SODIUM
RISEDRONATE SODIUM drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hangzhou Minsheng Binjiang Pharmaceutical CO Ltd | risedronate sodium | 60723-041 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
RISEDRONATE SODIUM drug variants containing CROSPOVIDONE
RISEDRONATE SODIUM drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
RISEDRONATE SODIUM drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-3099 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing D&C YELLOW NO. 10
Excipient focus: EDETATE DISODIUM
RISEDRONATE SODIUM drug variants containing EDETATE DISODIUM
RISEDRONATE SODIUM drug variants not containing EDETATE DISODIUM
Excipient focus: FD&C BLUE NO. 2
RISEDRONATE SODIUM drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | risedronate sodium | 65862-870 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 6
RISEDRONATE SODIUM drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Hangzhou Minsheng Binjiang Pharmaceutical CO Ltd | risedronate sodium | 60723-041 |
| Impax Generics | risedronate sodium hemi-pentahydrate | 0115-1426 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
RISEDRONATE SODIUM drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Greenstone LLC | risedronate sodium | 59762-0405 |
| Apotex Corp | risedronate sodium | 60505-3165 |
| Proficient Rx LP | risedronate sodium | 71205-714 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
RISEDRONATE SODIUM drug variants containing FERRIC OXIDE YELLOW
RISEDRONATE SODIUM drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-7771 |
| Hangzhou Minsheng Binjiang Pharmaceutical CO Ltd | risedronate sodium | 60723-041 |
| Aurobindo Pharma Limited | risedronate sodium | 65862-870 |
| Impax Generics | risedronate sodium hemi-pentahydrate | 0115-1426 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
RISEDRONATE SODIUM drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | risedronate sodium | 16714-870 |
| Sun Pharmaceutical Industires Inc | risedronate sodium | 63304-440 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
RISEDRONATE SODIUM drug variants containing HYDROXYPROPYL CELLULOSE
RISEDRONATE SODIUM drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
RISEDRONATE SODIUM drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | risedronate sodium | 16714-870 |
| Apotex Corp | risedronate sodium | 60505-3165 |
| Sun Pharmaceutical Industires Inc | risedronate sodium | 63304-440 |
| Proficient Rx LP | risedronate sodium | 71205-714 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
RISEDRONATE SODIUM drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-3099 |
| Aurobindo Pharma Limited | risedronate sodium | 65862-517 |
| Aurobindo Pharma Limited | risedronate sodium | 65862-870 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
RISEDRONATE SODIUM drug variants containing HYPROMELLOSES
RISEDRONATE SODIUM drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
RISEDRONATE SODIUM drug variants containing LACTOSE MONOHYDRATE
RISEDRONATE SODIUM drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
RISEDRONATE SODIUM drug variants containing MAGNESIUM STEARATE
RISEDRONATE SODIUM drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | risedronate sodium | 16714-870 |
| Sun Pharmaceutical Industires Inc | risedronate sodium | 63304-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
RISEDRONATE SODIUM drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | risedronate sodium | 47335-666 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing MANNITOL
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
RISEDRONATE SODIUM drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | risedronate sodium | 16714-870 |
| Sun Pharmaceutical Industires Inc | risedronate sodium | 63304-440 |
| Zydus Pharmaceuticals USA Inc | risedronate sodium | 68382-075 |
| Impax Generics | risedronate sodium hemi-pentahydrate | 0115-1426 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
RISEDRONATE SODIUM drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | risedronate sodium | 0430-0979 |
| Greenstone LLC | risedronate sodium | 59762-0407 |
| Zydus Lifesciences Limited | risedronate sodium | 70771-1436 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: POLYETHYLENE GLYCOL
RISEDRONATE SODIUM drug variants containing POLYETHYLENE GLYCOL
RISEDRONATE SODIUM drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
RISEDRONATE SODIUM drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-7771 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
RISEDRONATE SODIUM drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-3099 |
| Aurobindo Pharma Limited | risedronate sodium | 65862-517 |
| Aurobindo Pharma Limited | risedronate sodium | 65862-870 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
RISEDRONATE SODIUM drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | risedronate sodium | 60505-3165 |
| Aurobindo Pharma Limited | risedronate sodium | 65862-870 |
| Proficient Rx LP | risedronate sodium | 71205-714 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
RISEDRONATE SODIUM drug variants containing POLYSORBATE 80
RISEDRONATE SODIUM drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
RISEDRONATE SODIUM drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-7771 |
| Sun Pharmaceutical Industries Inc | risedronate sodium | 47335-666 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing POLYVINYL ALCOHOL
Excipient focus: PROPYLENE GLYCOL
RISEDRONATE SODIUM drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | risedronate sodium | 16714-870 |
| Sun Pharmaceutical Industires Inc | risedronate sodium | 63304-440 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
RISEDRONATE SODIUM drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | risedronate sodium | 16714-870 |
| Sun Pharmaceutical Industires Inc | risedronate sodium | 63304-440 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
RISEDRONATE SODIUM drug variants containing SILICON DIOXIDE
RISEDRONATE SODIUM drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
RISEDRONATE SODIUM drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | risedronate sodium | 0430-0979 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
RISEDRONATE SODIUM drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
RISEDRONATE SODIUM drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
RISEDRONATE SODIUM drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-3099 |
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-7771 |
| NorthStar RxLLC | risedronate sodium | 16714-870 |
| Sun Pharmaceutical Industires Inc | risedronate sodium | 63304-440 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
RISEDRONATE SODIUM drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-3099 |
| Teva Pharmaceuticals USA Inc | risedronate sodium | 0093-7771 |
| Sun Pharmaceutical Industries Inc | risedronate sodium | 47335-666 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
RISEDRONATE SODIUM drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | risedronate sodium | 0430-0979 |
| Greenstone LLC | risedronate sodium | 59762-0407 |
| Zydus Pharmaceuticals USA Inc | risedronate sodium | 68382-075 |
| Zydus Lifesciences Limited | risedronate sodium | 70771-1436 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing STEARIC ACID
Excipient focus: TALC
RISEDRONATE SODIUM drug variants containing TALC
RISEDRONATE SODIUM drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
RISEDRONATE SODIUM drug variants containing TITANIUM DIOXIDE
RISEDRONATE SODIUM drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
RISEDRONATE SODIUM drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Hangzhou Minsheng Binjiang Pharmaceutical CO Ltd | risedronate sodium | 60723-041 |
| >Company | >Ingredient | >NDC |
RISEDRONATE SODIUM drug variants not containing TRIACETIN
Excipient focus: TRIETHYL CITRATE
RISEDRONATE SODIUM drug variants containing TRIETHYL CITRATE
RISEDRONATE SODIUM drug variants not containing TRIETHYL CITRATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
